Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== Intracranial tumor informed consent ====== [[Informed consent]] is the integral part of good medical practice in patients with [[brain tumor]]s. Capacity to [[consent]] may be affected by the brain disorder or its treatment. Hewins et al., intend to draw upon the current [[neurooncology]] [[literature]] to discuss the influence [[intracranial tumor]]s have upon patients' capacity to consent to treatment and research. They performed a [[systematic review]] of studies of capacity to consent for treatment or research in patients with intracranial tumours. The search retrieved 1597 [[paper]]s of which 8 were considered eligible for [[review]]. Although there are obvious inherent limitations to solely assessing cognition, most research consistently demonstrated increased risk of incapacity in brain tumour patients with cognitive impairment. Specific items in cognitive screening batteries, for example [[Semantic Verbal Fluency Test]] (SVFT), [[Hopkins Verbal Learning Test]] (HVLT-Recall), and [[Trail Making Test A/B]] (TMT), are simple, easily applied tests that may act as significant [[red flag]]s to identify patients at increased risk of [[incapacity]] and who subsequently will require additional cognitive/psychiatric evaluation or more formal tests for capacity to [[consent]] for treatment or [[research]] ((Hewins W, Zienius K, Rogers JL, Kerrigan S, Bernstein M, Grant R. The Effects of Brain Tumours upon Medical Decision-Making Capacity. Curr Oncol Rep. 2019 May 2;21(6):55. doi: 10.1007/s11912-019-0793-3. Review. PubMed PMID: 31049786. )). intracranial_tumor_informed_consent.txt Last modified: 2024/06/07 02:53by 127.0.0.1